Diligence memo · auto-generated · as of July 1, 2026

HCPlexus, Inc.

HCPlexus, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

HCPlexus, Inc. operates in Other Health Care, based in DARIEN.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

HCPlexus, Inc. has raised $10M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $10M on 2010-11-23.

Most recent recorded round closed around 2010-11-23.

Valuation (modeled)modeled

Provath models HCPlexus, Inc. at approximately $202M (range $13M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.74× the median modeled value of Series A Other Health Care companies in 2010–2012 (199 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 15.6 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 76% of Other Health Care peers (5376 compared).

Modeled value ranks above 88% of those peers.

Closest niche peers: Barrx Medical Inc, Cas Medical Systems Inc, Icad Inc, Cardiosolutions Inc, Ophthonix Inc.

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.